TFRC and cancer: Intracellular iron supplementation selectively sensitizes cancer cells to high-dose VC by disrupting the oxidative metabolism, and we consider that 68Ga-citrate PET imaging may be able to screen out tumor patients with high TFR expression, which could be more sensitive to VC treatment combined with iron supplementation.